Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.
Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.
复制标题
DOI:
10.1177/1099800413483545
复制
发表时间:
2014-04
影响因子:
2.5
通讯作者:
Jackson-Cook C
中科院分区:
文献类型:
--
作者:
Lyon D;Elmore L;Aboalela N;Merrill-Schools J;McCain N;Starkweather A;Elswick RK Jr;Jackson-Cook C
Due to recent treatment advances, there have been improvements in the proportion of women surviving a diagnosis of breast cancer (BC). However, many of these survivors report persistent adverse side effects following treatment, such as cognitive dysfunction, depressive symptoms, anxiety, fatigue, sleep disturbances, and pain. Investigators have examined circulating levels of inflammatory markers, particularly serum cytokines, for a potential causal relationship to the development/persistence of these psychoneurological symptoms (PNS). While inflammatory activation, resulting from perceived stress or other factors, may directly contribute to the development of PNS, we offer an alternative hypothesis, suggesting that these symptoms are an early step in a cascade of biological changes leading to epigenetic alterations at the level of deoxyribonucleic acid (DNA) methylation, histone modifications, and/or chromatin structure/chromosomal instability. Given that epigenetic patterns have plasticity, if this conjectured relationship between epigenomic/acquired genomic alterations and the development/persistence of PNS is confirmed, it could provide foundational knowledge for future research leading to the recognition of predictive markers and/or treatments to alleviate PNS in women with BC. In this article, we discuss an evolving theory of the biological basis of PNS, integrating knowledge related to inflammation and DNA repair in the context of genetic and epigenetic science to expand the paradigm for understanding symptom acquisition/persistence following chemotherapy.
登录
查看更多内容
DOI:
10.1186/bcr2871
发表时间:
2011-05-25
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Stefansson OA;Esteller M
通讯作者:
Esteller M
影响因子:
2.7
作者:
Day, Jeremy J;Sweatt, J David
通讯作者:
Sweatt, J David
影响因子:
50.3
作者:
Chang CJ;Yang JY;Xia W;Chen CT;Xie X;Chao CH;Woodward WA;Hsu JM;Hortobagyi GN;Hung MC
通讯作者:
Hung MC
影响因子:
2.3
作者:
Bartsch, Helmut;Nair, Jagadeesan
通讯作者:
Nair, Jagadeesan
影响因子:
8.4
作者:
Butcher, Darci T.;Rodenhiser, David I.
通讯作者:
Rodenhiser, David I.